Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms | NEJM
2014 WHO Clinical Molecular and Pathological (WHO-CMP) Diagnostic
Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies - ScienceDirect
Essential Thrombocythemia disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials
IJMS | Free Full-Text | Recent Advances in the Use of Molecular Analyses to Inform the Diagnosis and Prognosis of Patients with Polycythaemia Vera
JAK2 V617F positive hypercellular essential thrombocythemia (platelets... | Download Scientific Diagram
Acute Lymphoblastic Leukemia Arising in CALR Mutated Essential Thrombocythemia
Single Nucleotide Polymorphism (SNP)-Based Loss of Heterozygosity (LOH) Testing by Real Time PCR in Patients Suspect of Myeloproliferative Disease | PLOS ONE
Study of Bomedemstat in Participants With Essential Thrombocythemia (IMG-7289-CTP-201/MK-3543-003)
Copy number alterations and copy-neutral loss of heterozygosity in Ukrainian patients with primary myelofibrosis | Experimental oncology
Assessing the thrombotic risk of patients with essential thrombocythemia in the genomic era | Leukemia
Primary thrombocytosis in children | Haematologica
How I treat essential thrombocythemia - ScienceDirect
Single Nucleotide Polymorphism (SNP)-Based Loss of Heterozygosity (LOH) Testing by Real Time PCR in Patients Suspect of Myeloproliferative Disease | PLOS ONE
Acute Lymphoblastic Leukemia Arising in CALR Mutated Essential Thrombocythemia
Cureus | JAK2 and TET2 Mutation in Polycythemia Vera | Article
Occurrence of a paroxysmal nocturnal hemoglobinuria clone in an essential thrombocythemia: a link between <i>PIGV</i> and <i>MPL</i> | Haematologica
Cells | Free Full-Text | MPN: The Molecular Drivers of Disease Initiation, Progression and Transformation and their Effect on Treatment
Essential thrombocythaemia with mutation in MPL: clinicopathological correlation and comparison with JAK2V617F-mutated and CALR-mutated genotypes | Journal of Clinical Pathology
Mutation status of essential thrombocythemia and primary myelofibrosis defines clinical outcome | Haematologica
Essential thrombocythemia treatment algorithm 2018 | Blood Cancer Journal
A,B. Evaluation of loss of heterozygosity (LOH) on chromosome 22q in... | Download Scientific Diagram
Change of the 2008/2016 WHO Criteria into European Clinical, Lab- oratory Molecular and Pathological (ECMP/CLMP) Classification
Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation - ScienceDirect
